Cohera Medical Inc. inches past the midpoint of $25 million Series C round.

Cohera Medical Inc. has raised $12.7 million in investment funding, nudging past the halfway point to what it hopes will be a $25 million Series C round.
The funding comes in the form of convertible notes and was raised from existing investors, CEO Patrick Daly said. Daly expects Cohera’s 28 existing investors to contribute a total of $15 million toward the Series C round. He hopes to source the remaining $10 million from new investors in the coming months.
Medical device giant Medtronic unveils a 1st look from its global Symplicity renal denervation...
Stentys launches a clinical trial aimed at backing a pre-market approval application with the FDA for...
Medtronic is about 2/3 of the way through a restructuring plan involving 2,000 layoffs worldwide,...
Boston Scientific denies allegations by stents rival OrbusNeich that it tried to block the seizure of...
Hologic wins FDA approval for its new C-View 2D imaging software for use with its 3D breast...